Agilon Health, Inc. <AGL.N>: Benchmark Raises Target Price to $140 From $95
AGL•Related News
Climb Bio Q2 FY26 net loss widens 55.73% to $13.5 million
CLYM•
Harrow to buy dry eye nasal spray Tyrvaya from Viatris for up to $100 million
HROW•
Immunocore Q2 FY26 net loss narrows to $0.8 million; revenue rises 18% to $115.9 million
IMCR•
KVH returns to profit in Q2 FY26; revenue rises 27% to $33.7 million
KVHI•
Constellation Energy gains after raising annual profit forecast, Q2 beat
CEG•